Education
About Us
Working with TipRanks
Follow Us
Envoy Medical (COCH)
NASDAQ:COCH
COCH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.21 - $5.26
Previous CloseN/A
Volume61.49K
Average Volume (3M)14.48K
Market Cap
$31.56M
Enterprise Value$44.68M
Total Cash (Recent Filing)$4.95M
Total Debt (Recent Filing)$5.36M
Price to Earnings (P/E)―
Beta0.37
Next Earnings
May 14, 2025EPS Estimate
-0.31Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.32
Shares Outstanding21,326,618
10 Day Avg. Volume8,756
30 Day Avg. Volume14,480
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)99.83
Price to Cash Flow (P/CF)-2.60
P/FCF Ratio0.00
Enterprise Value/Market Cap1.42
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-94.45
Enterprise Value/Ebitda-2.00
Forecast
1Y Price Target
$6.75Price Target Upside362.33% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
---
Bulls Say, Bears Say
Bulls Say
Market PotentialThe company believes there is a significant market potential, with an expected annual opportunity exceeding $750 million by 2026 in the U.S., and additional international expansion opportunities.
Product InnovationEnvoy Medical's Acclaim CI, a fully implanted cochlear implant, addresses a significant market opportunity by eliminating the need for an external component.
Regulatory ProgressThe recent IDE approval for the Acclaim CI with the FDA to begin clinical testing is a significant milestone for the company.
Bears Say
Clinical And Commercial RisksEnvoy Medical balances high risks with large upside opportunities, with a billion dollars market potential presenting high rewards for the risks.
Revenue And RiskEnvoy Medical is in an early/clinical/commercialization stage, generating minimal revenue and facing high risks associated with clinical trials or commercial failures.
---
Ownership Overview
49.66% Insiders
2.19% Mutual Funds
5.70% Other Institutional Investors
40.55% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
COCH FAQ
What was Envoy Medical’s price range in the past 12 months?
Envoy Medical lowest stock price was $1.21 and its highest was $5.26 in the past 12 months.
What is Envoy Medical’s market cap?
Envoy Medical’s market cap is $31.56M.
When is Envoy Medical’s upcoming earnings report date?
Envoy Medical’s upcoming earnings report date is May 14, 2025 which is in 18 days.
How were Envoy Medical’s earnings last quarter?
Envoy Medical released its earnings results on Mar 31, 2025. The company reported -$0.53 earnings per share for the quarter, missing the consensus estimate of -$0.358 by -$0.172.
Is Envoy Medical overvalued?
According to Wall Street analysts Envoy Medical’s price is currently Undervalued.
Does Envoy Medical pay dividends?
Envoy Medical does not currently pay dividends.
What is Envoy Medical’s EPS estimate?
Envoy Medical’s EPS estimate is -0.31.
How many shares outstanding does Envoy Medical have?
Envoy Medical has 21,326,618 shares outstanding.
What happened to Envoy Medical’s price movement after its last earnings report?
Envoy Medical reported an EPS of -$0.53 in its last earnings report, missing expectations of -$0.358. Following the earnings report the stock price went down -4.412%.
Which hedge fund is a major shareholder of Envoy Medical?
Currently, no hedge funds are holding shares in COCH
---
Envoy Medical Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$6.75 (362.33% Upside)
$6.75 (362.33% Upside)
Hedge Fund Trend
Decreased
By 297.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $5.7K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-70.75%
12-Months-Change
Fundamentals
Return on Equity
1697.39%
Trailing 12-Months
Asset Growth
51.02%
Trailing 12-Months
Company Description
Envoy Medical
Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices; and Acclaim cochlear implants. Envoy Medical Corporation was formerly known as St. Croix Medical, Inc. and changed its name to Envoy Medical Corporation in December 2004. The company was founded in 1995 and is based in White Bear Lake, Minnesota.
---
COCH Stock 12 Month Forecast
Average Price Target
$6.75
▲(362.33% Upside)
Technical Analysis
Best Analysts Covering COCH
1 Year
1 Year Success Rate
2/11 ratings generated profit
1 Year Average Return
-32.60%
reiterated a buy rating 27 days ago
Copying Frank Takkinen's trades and holding each position for 1 Year would result in 18.18% of your transactions generating a profit, with an average return of -32.60% per trade.
---